News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
243 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17909)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (309)
2 (217)
3 (119)
4 (10)
5 (15)
6 (240)
7 (330)
8 (243)
9 (293)
10 (101)
11 (2)
12 (13)
13 (228)
14 (250)
15 (299)
16 (255)
17 (104)
18 (5)
19 (7)
20 (208)
21 (277)
22 (218)
23 (219)
24 (80)
25 (4)
26 (9)
27 (24)
28 (229)
29 (306)
30 (261)
31 (124)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Biotech Beach
Puma Biotechnology to Present at Bank of America Merrill Lynch Health Care Conference 2019
The conference will be held at Encore at the Wynn in Las Vegas.
May 8, 2019
·
1 min read
Business
Provention Bio Reports First Quarter 2019 Financial Results
PROTECT Pivotal Phase 3 Clinical Study Initiated in Patients with Recent Onset Type 1 Diabetes Top line Data Results for PRINCE and At-Risk Clinical Trials Expected in 2019
May 8, 2019
·
8 min read
NATIONWIDE CHILDREN’S HOSPITAL DEDICATES LOBBY IN HONOR OF THE CHARLOTTE AND GWENYTH GRAY FOUNDATION TO CURE BATTEN DISEASE
Nationwide Children’s Hospital, one of the largest and most comprehensive pediatric academic medical centers in the world, has dedicated its lobby in a ceremony honoring of The Charlotte and Gwenyth Gray Foundation to Cure Batten Disease.
May 8, 2019
·
3 min read
Business
CORRECTING and REPLACING McKesson Reports Fiscal 2019 Fourth-Quarter and Full-Year Results
McKesson Corporation reported that revenues for the fourth quarter ended March 31, 2019, were $52.4 billion compared to $51.6 billion a year ago, an increase of 2% on a reported basis and an increase of 3% on an FX-adjusted basis.
May 8, 2019
·
18 min read
Deals
MYOS RENS Technology Reports 161% Increase in Revenues, 238% Increase in Gross Profit in First Quarter 2019
MYOS RENS Technology Inc. announced its financial results for the first quarter ended March 31, 2019.
May 8, 2019
·
9 min read
Business
Prometic strengthens its leadership with a new management structure and the appointment of three new directors
Prometic Life Sciences Inc. is pleased to announce a new management structure to provide leadership to the Corporation and the appointment of Dr. Gary Bridger, Mr. Timothy Wach and Mr. Neil Klompas to the Board of Directors.
May 8, 2019
·
7 min read
Deals
Takeda Simplifies Portfolio and Accelerates Deleveraging Through Two Divestitures
Takeda Pharmaceutical Company Limited announced that it has entered into agreements to divest its Xiidra® 5% product to Novartis and its TachoSil® Fibrin Sealant Patch to Ethicon as part of its strategy to focus on business areas core to its long-term growth and facilitate rapid deleveraging following its acquisition of Shire.
May 8, 2019
·
7 min read
Deals
Fuse Medical Reports First Quarter 2019 Results
Fuse Medical, Inc., announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2019, with the United States Securities and Exchange Commission, on Tuesday, May 7, 2019.
May 8, 2019
·
3 min read
Deals
Cortexyme, Inc. Announces Pricing of Initial Public Offering
Cortexyme, Inc. announced that it has priced its initial public offering of 4,412,000 shares of its common stock at a price to the public of $17.00 per share, before underwriting discounts and commissions.
May 8, 2019
·
3 min read
Deals
Prometic reports its 2019 first quarter financial results
Completion of recapitalization transactions and $75 million in gross proceeds secured from equity offering
May 8, 2019
·
12 min read
Previous
19 of 25
Next